Viteyes AREDS 2 Plus Omega-3 (3 Month Supply)

Price: $64.95
Product prices and availability are accurate as of 2021-12-08 04:32:11 MST and are subject to change. Any price and availability information displayed on http://www.amazon.com/ at the time of purchase will apply to the purchase of this product.
CERTAIN CONTENT THAT APPEARS ON THIS SITE COMES FROM AMAZON SERVICES LLC. THIS CONTENT IS PROVIDED 'AS IS' AND IS SUBJECT TO CHANGE OR REMOVAL AT ANY TIME.

Manufacturer Description

Viteyes AREDS 2 Plus Omega-3 is based on the findings of the AREDS 2 study, plus 1,000 mg of omega-3. Completed in 2013, AREDS 2 was a 5-year follow-up study by the National Eye Institute (NEI) of the original AREDS study. AREDS 2 resulted in the NEI's recommendation to revise the original AREDS formula to help further slow the progression of AMD.* Viteyes AREDS 2 Plus Omega-3 contains Vitamin C 500 mg, Vitamin E 400 IU, Zinc 25 mg, Copper 2 mg, Lutein 10 mg, Zeaxanthin 2 mg, & Omega-3 1,000 mg. AREDS 2 analyzed the AREDS formula with & without beta-carotene, due to the risk of lung cancer for smokers/former smokers. The AREDS 2 study also researched adding lutein & zeaxanthin. AREDS 2 participants who took lutein & zeaxanthin and no beta-carotene reduced their risk of developing advanced stages of AMD by 18% compared to those in AREDS 2 who took the original AREDS with beta-carotene. As a result, NEI's AREDS 2 suggests modifying the AREDS formula by omitting beta-carotene & adding lutein & zeaxanthin. Zinc Levels: In the original AREDS study, the dose for zinc was high (80 mg) because a previous small trial had found that high-dose zinc was beneficial for AMD. However, some nutritionists were concerned the dose was too high.* The AREDS 2 study tested zinc at 80 mg & 25 mg. The results showed that when lowering zinc there was "no statistically significant effect on progression to advanced AMD."** (*NEI website 2013. AREDS 2 Media Q&A www.nei.nih.gov/areds2/MediaQandA.asp. **AREDS2 Research Group. "Lutein/Zeaxanthin and Omega-3 Fatty Acids for Age-Related Macular Degeneration. The Age-Related Eye Disease Study 2 (AREDS2) Controlled Randomized Clinical Trial." JAMA, published online May 5, 2013). These statements have not been evaluated by the Food & Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

Product Features

Viteyes® AREDS 2 Plus Omega-3 is based on the findings of National Eye Institutes AREDS 2 study, plus 1,000 mg of omega-3 in 3 daily softgels. Viteyes® AREDS 2 Plus Omega-3 is beta-carotene free appropriate for smokers and former smokers. Recommended by physicians worldwide. Manufactured in the U.S.A by Vitamin Health, Inc. Take with Viteyes Multivitamin AREDS 2 Companion to get all of your daily supplement needs.

Write a Review